Mixovert Tablet is a combination of Cinnarizine (20mg) and Dimenhydrinate (40mg) indicated for the treatment of nausea, vomiting, and vertigo associated with motion sickness. Cinnarizine, a calcium channel blocker, exerts its therapeutic effect by stabilizing the vestibular apparatus and reducing the stimulation of the vestibular system. Dimenhydrinate, a synthetic antihistamine, acts as a potent antiemetic, inhibiting the release of histamine and other neurotransmitters responsible for emesis. The combination of these two agents synergistically enhances the therapeutic efficacy in alleviating the symptoms of motion sickness. Mixovert Tablet is available in a convenient oral formulation, allowing for easy administration. The recommended adult dose is one tablet to be taken 30 minutes before travel or as needed. The tablet is contraindicated in patients with hypersensitivity to any component, pregnancy, and breastfeeding. As with all medications, Mixovert Tablet should be used under the guidance of a healthcare professional, and the patient should be carefully monitored for any adverse reactions.